Quest Diagnostics (DGX) Tops Q4 EPS by 1c; Guides In-line for Fy10
Tweet Send to a Friend
Quest Diagnostics Incorporated (NYSE: DGX) reports Q4 EPS of $0.97, 1 cent better than estimates. Revenues were $1.8 billion ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
